Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SHALBY

SHALBY

HealthcareHealthcare Services₹1283 cr market cap
₹122.02 ▲ +2.57% today As of 19 Nov 2026
52-week low ₹113.3952-week high ₹230.31

-48.3% from the 52-week high · +4.9% above the low

Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat and currently employs 2,678 full-time employees. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The firm encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and reconstructive surgery, rheumatology, cosmetics and dermatology, homecare, bariatric surgery, gynecology, in vitro fertilization (IVF) and surrogacy counseling, homecare, among others.

The short version. SHALBY reported revenue of ₹313 crore for Sep 2026, up 9.8% from a year earlier. Net profit was ₹8 crore (up 0.0% year on year). Return on equity was 3.7% in Mar 2026. Promoter holding was 74.33% in Sep 2026, up 0.06 points over 8 quarters.

1 · The price

How has the stock traded?

SHALBY trades 48.3% below its 52-week high and 4.9% above its 52-week low.

Change over period: —

1M-5.8%
3M-23.5%
6M-28.7%
1Y-46.9%

2 · The business

Is it growing?

Sales, year on year+9.8%

Sep 2026 revenue of ₹313 cr.

Profit, year on year+0.0%

Sep 2026 net profit of ₹8 cr.

Net margin2.6%

0.3 pts lower than a year earlier.

3-year growth-18.0% profit

Revenue compounded at 12.2% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue313331287272285296265276
Net profit81118289-11-3
Net margin %2.63.36.40.62.93.0-4.2-1.1
EPS (₹)0.771.01.70.160.780.83-1.02-0.28

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue11411087934805699431487461
Net profit376836854422832
Net margin %3.30.68.98.47.79.85.76.9
EPS (₹)3.460.587.736.275.03.932.552.93

3 · The quality

How well does it turn capital into profit?

Return on equity was 3.7% in Mar 2026; debt to equity is 0.54.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %3.70.68.37.3
Return on capital %7.97.611.210.2
EBITDA margin %14.514.420.619.2
Net margin %3.20.68.88.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR12.2%21.6%
Profit CAGR-18.0%-2.5%
Debt to equity0.54
Interest cover2.6x
Current ratio1.25
P/E ratio33.4

4 · The owners

Who holds it, and are they adding?

Promoter holding74.33%

Up 0.06 pts over 8 quarters.

Foreign institutions4.65%

Unchanged over 8 quarters.

Domestic institutions0.31%

Up 0.17 pts over 8 quarters.

Mutual fund schemes3

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter74.2774.2774.2774.3374.3374.3374.3374.33+0.06
FII4.654.545.24.644.474.364.464.650.0
DII0.140.180.20.20.20.250.30.31+0.17
Public20.2520.3319.6420.1820.3520.4120.2620.08-0.17

Mutual fund holdings · Oct 2026

3 schemes hold this stock

3 the month before.

  • Groww BSE Hospitals ETF0.15% of NAV
  • Motilal Oswal BSE Healthcare ETF0.02% of NAV
  • Bandhan BSE Healthcare Index Fund0.02% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SHALBY are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SHALBY

What is the SHALBY share price?

SHALBY (SHALBY) last closed at ₹122.02, up 2.57% on the day. Its 52-week range is ₹113.39 to ₹230.31.

What is the market cap of SHALBY?

SHALBY has a market capitalisation of about ₹1,283 crore. Its price-to-earnings ratio is 33.4.

How are SHALBY's latest results?

SHALBY reported revenue of ₹313 crore for Sep 2026, up 9.8% from a year earlier. Net profit was ₹8 crore (up 0.0% year on year). Return on equity was 3.7% in Mar 2026. Promoter holding was 74.33% in Sep 2026, up 0.06 points over 8 quarters.

Who owns SHALBY?

As of Sep 2026, shareholding was: Promoter 74.33%, FII 4.65%, DII 0.31%, Public 20.08%.

How many mutual funds hold SHALBY?

3 mutual fund schemes held SHALBY in October 2026. That compares with 3 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 19 Sep 2024 · Final Dividend - Rs. 1.2
  • 08 Aug 2023 · Final Dividend - Rs. 1.2
  • 19 Sep 2022 · Final Dividend - Rs. 1
  • 17 Sep 2021 · Final Dividend - Rs. 1
  • 04 Sep 2020 · Final Dividend - Rs. 0.5
  • 16 Aug 2019 · Final Dividend - Rs. 0.5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.